title: CD2 + CD19 + acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Groupe d'Etude Immunologique des Leucémies (G.E.I.L.).
abstract: A small population of CD2 + CD19 + lymphoid cells have been suggested to be common lymphoid progenitors. CD2 + CD19 + biphenotypic ALL account for less than 2% of ALL. We analysed the clinical and laboratory features of a series of 16 patients with CD2 + CD19 + ALL. The incidence of tumoural syndrome was comparable to a previously published series of pre B-ALL but significantly different from that of T-ALL. The mean age of the 11 children of this series was 101 +/- 46 months, and differed significantly from that of children with pre B-ALL (P < 0.01). Complete remission was obtained for all patients except two adults. Only three relapses have been observed. Regardless of the presence of CD2 +, the 16 ALL could be classified as pre B-ALL, according to the nomenclature used by the GEIL. Nine samples could be analysed by Southern blotting. Seven had rearranged IGH genes, usually on both chromosomes. IGK rearrangement was observed in three cases. Only one case had rearranged both TCRG and TCR beta. The patterns observed here and those reported previously follow that of the pre B-ALL which confirms the engagement of most CD2 + CD19 + biphenotypic ALL in the B-lineage.
authors.affiliation: Laboratoire Hématologie et Pédiatrie, Hôpital Charles Nicolle, Rouen, France.
authors.forename: B
authors.initials: B
authors.lastname: Lenormand
authors.forename: J P
authors.initials: JP
authors.lastname: Vannier
authors.forename: M C
authors.initials: MC
authors.lastname: Bene
authors.forename: A
authors.initials: A
authors.lastname: Falkenrodt
authors.forename: C
authors.initials: C
authors.lastname: Bayle
authors.forename: M
authors.initials: M
authors.lastname: Favre
authors.forename: R
authors.initials: R
authors.lastname: Garand
authors.forename: A M
authors.initials: AM
authors.lastname: Griveau
authors.forename: M T
authors.initials: MT
authors.lastname: Briquet
authors.forename: O
authors.initials: O
authors.lastname: Reman
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000032:analysis*; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte / Q000032:analysis*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis*; D015139:Blotting, Southern; D018801:CD2 Antigens; D002648:Child; D005500:Follow-Up Studies; D015321:Gene Rearrangement; D015329:Gene Rearrangement, T-Lymphocyte; D005803:Genes, Immunoglobulin; D006801:Humans; D016130:Immunophenotyping / Q000379:methods; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000276:immunology*; D011971:Receptors, Immunologic / Q000032:analysis*
chemical_list: D015703:Antigens, CD; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte; D000945:Antigens, Differentiation, T-Lymphocyte; D018801:CD2 Antigens; D011971:Receptors, Immunologic